ophthalmology
Oxford Biomedica signs ophthalmology R&D deal with Santen
Richard Staines
gene therapy, ophthalmology, Oxford Biomedica, R&D, santen
0 Comment
Partner Content/ Partner content/ Press releases
Registration opens for SMi’s 3rd Annual Ophthalmic Drugs Conference
Neill Howard
Ocular, ophthalmology
0 Comment
Insights into Ophthalmology
NICE backs Alimera’s three-year uveitis implant
Phil Taylor
alimera, NICE, ophthalmology, Rare diseases
0 Comment
Novartis shows off pipeline – including 25 potential blockbusters
Richard Staines
cancer, Novartis, ophthalmology, R&D, Rare diseases, respiratory
0 Comment
Ping An completes trial of AI-based retinal disease screening system
Richard Staines
artificial intelligence, ophthalmology
0 Comment
News/ News/ Oncology/ Top stories
J&J unveils top pipeline prospects, with main focus on cancer
Richard Staines
cancer, gastroenterology, infectious diseases, inflammatory diseases, Johnson & Johnson, neurology, ophthalmology, R&D
0 Comment